Tag: NASDAQ:ARNA

Finance

Notable Movers: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Bayer AG (ADR) (OTCMKTS:BAYRY)

Pfizer Inc (NYSE:PFE) Insider Geno J. Germano unloaded 30,000 shares of the stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $29.68, for a total value of $890,400.00. Following the transaction, the insider now directly owns 263,495 shares of the company’s stock, valued at approximately $7,820,532. Pfizer Inc. (NYSE:PFE) stock performance … Continue reading Notable Movers: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Bayer AG (ADR) (OTCMKTS:BAYRY)

Jason Knox
Gilead Sciences GILD NASDAQ:GILD
Finance

Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

InterMune, Inc. (NASDAQ:ITMN) on 27 May 2014 announced that it has resubmitted its pirfenidone New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2010. Pirfenidone is being developed for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF). InterMune Inc (NASDAQ:ITMN) stock performance was -0.88% in last session and finished … Continue reading Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

Kristen Barton
Finance

Hot Stocks: VMware, Inc. (NYSE:VMW), Honeywell International Inc. (NYSE:HON), AbbVie Inc (NYSE:ABBV), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

VMware, Inc (NYSE:VMW) COO Carl M. Eschenbach unloaded 5,897 shares of the stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $95.05, for a total value of $560,509.85. Following the sale, the chief operating officer now directly owns 81,879 shares of the company’s stock, valued at approximately $7,782,599. VMware, Inc. (NYSE:VMW) stock performance was 1.54% in last … Continue reading Hot Stocks: VMware, Inc. (NYSE:VMW), Honeywell International Inc. (NYSE:HON), AbbVie Inc (NYSE:ABBV), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Richard Atkins
Finance

Stocks To Watch: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), Galena Biopharma Inc (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD)

Effective May 15, 2014, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) granted an exemption to BlackRock, Inc. (NYSE: BLK), together with its subsidiaries, affiliates and associates (collectively, “BlackRock”) under the Company’s Section 382 Rights Agreement, dated as of October 31, 2013, between the Company and Computershare Trust Company, N.A., as rights agent (the “Rights Agreement”) following the determination by a designated committee of the Board of Directors (the … Continue reading Stocks To Watch: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), Galena Biopharma Inc (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD)

Jason Knox
Finance

Hot Biotech Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD), Chelsea Therapeutics (NASDAQ:CHTP)

MannKind Corporation (NASDAQ:MNKD) loss of 14 cents per share in the first quarter of 2014 was wider than the Zacks Consensus Estimate by a penny but narrower than the year-ago loss by a penny. MannKind Corporation (NASDAQ:MNKD) did not generate any revenue in the first quarter of 2014, as in the year-ago quarter. Research and development (R&D) expenses remained flat at $26.2 million in the … Continue reading Hot Biotech Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD), Chelsea Therapeutics (NASDAQ:CHTP)

Adam Keintzel
Finance

Trending Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sprint Corporation (NYSE:S), Facebook (NASDAQ:FB), 58.com Inc (ADR) (NYSE:WUBA)

Arena Pharmaceuticals, Inc (NASDAQ:ARNA) shares fell 5.1% during trading on Monday after the company announced weaker than expected quarterly earnings, AnalystRatings Network reports. The company traded as low as $6.82 and last traded at $6.82, with a volume of 4,382,908 shares. The stock had previously closed at $7.19. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -4.87% in last session and finished the day at $6.84. … Continue reading Trending Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sprint Corporation (NYSE:S), Facebook (NASDAQ:FB), 58.com Inc (ADR) (NYSE:WUBA)

Mark Doerr